These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29331267)

  • 21. Molecular characterization and antimicrobial susceptibility of tcdA-negative Clostridium difficile isolates from Guangzhou, China.
    Lidan C; Linhai L; Yang L; Zhaohui S; Xiaoyan H; Yuling S
    Diagn Microbiol Infect Dis; 2016 Apr; 84(4):361-5. PubMed ID: 26867962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B.
    Devera TS; Lang GA; Lanis JM; Rampuria P; Gilmore CL; James JA; Ballard JD; Lang ML
    Infect Immun; 2016 Jan; 84(1):194-204. PubMed ID: 26502913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response.
    Popoff MR
    Toxicon; 2018 Jul; 149():54-64. PubMed ID: 29146177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of Clostridium difficile isolates from ICU colonized patients revealed alert to ST-37 (RT 017) isolates.
    Yang J; Zhang X; Liu X; Cai L; Feng P; Wang X; Zong Z
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):161-163. PubMed ID: 28800896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Clostridium difficile toxin A and B by 1,2-cyclohexanedione modification of an arginine residue.
    Balfanz J; Rautenberg P
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1364-70. PubMed ID: 2610698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile.
    Lemee L; Dhalluin A; Testelin S; Mattrat MA; Maillard K; Lemeland JF; Pons JL
    J Clin Microbiol; 2004 Dec; 42(12):5710-4. PubMed ID: 15583303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2,4-Disubstituted 5-Nitroimidazoles Potent against Clostridium difficile.
    Spitz C; Mathias F; Péchiné S; Doan THD; Innocent J; Pellissier S; Di Giorgio C; Crozet MD; Janoir C; Vanelle P
    ChemMedChem; 2019 Mar; 14(5):561-569. PubMed ID: 30644169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-time multiplex polymerase chain reaction assay for rapid detection of Clostridium difficile toxin-encoding strains.
    Houser BA; Hattel AL; Jayarao BM
    Foodborne Pathog Dis; 2010 Jun; 7(6):719-26. PubMed ID: 20113206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
    Chen S; Sun C; Wang H; Wang J
    Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile Toxin Biology.
    Aktories K; Schwan C; Jank T
    Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470.
    Huelsenbeck J; Dreger S; Gerhard R; Barth H; Just I; Genth H
    Infect Immun; 2007 Feb; 75(2):801-9. PubMed ID: 17145947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: impact on laboratory diagnosis.
    Kim H; Riley TV; Kim M; Kim CK; Yong D; Lee K; Chong Y; Park JW
    J Clin Microbiol; 2008 Mar; 46(3):1116-7. PubMed ID: 18199783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas.
    Jiang ZD; DuPont HL; La Rocco M; Garey KW
    J Clin Pathol; 2010 Apr; 63(4):355-8. PubMed ID: 20354207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.
    Persson S; Torpdahl M; Olsen KE
    Clin Microbiol Infect; 2008 Nov; 14(11):1057-64. PubMed ID: 19040478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B.
    Yuan P; Zhang H; Cai C; Zhu S; Zhou Y; Yang X; He R; Li C; Guo S; Li S; Huang T; Perez-Cordon G; Feng H; Wei W
    Cell Res; 2015 Feb; 25(2):157-68. PubMed ID: 25547119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical Space Exploration around Thieno[3,2-
    Shao X; AbdelKhalek A; Abutaleb NS; Velagapudi UK; Yoganathan S; Seleem MN; Talele TT
    J Med Chem; 2019 Nov; 62(21):9772-9791. PubMed ID: 31584822
    [No Abstract]   [Full Text] [Related]  

  • 38. A MLST Clade 2 Clostridium difficile strain with a variant TcdB induces severe inflammatory and oxidative response associated with mucosal disruption.
    Costa CL; López-Ureña D; de Oliveira Assis T; Ribeiro RA; Silva RO; Rupnik M; Wilcox MH; de Carvalho AF; do Carmo AO; Dias AA; de Carvalho CB; Chaves-Olarte E; Rodríguez C; Quesada-Gómez C; de Castro Brito GA
    Anaerobe; 2016 Aug; 40():76-84. PubMed ID: 27311833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid and simple method for detecting the toxin B gene of Clostridium difficile in stool specimens by loop-mediated isothermal amplification.
    Kato H; Yokoyama T; Kato H; Arakawa Y
    J Clin Microbiol; 2005 Dec; 43(12):6108-12. PubMed ID: 16333105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin.
    Spyres LM; Daniel J; Hensley A; Qa'Dan M; Ortiz-Leduc W; Ballard JD
    Infect Immun; 2003 Jun; 71(6):3294-301. PubMed ID: 12761111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.